Thomas R Nirschl

Thomas R Nirschl

UNVERIFIED PROFILE

Are you Thomas R Nirschl?   Register this Author

Register author
Thomas R Nirschl

Thomas R Nirschl

Publications by authors named "Thomas R Nirschl"

Are you Thomas R Nirschl?   Register this Author

13Publications

542Reads

18Profile Views

Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer.

Eur Urol Oncol 2019 Feb 26. Epub 2019 Feb 26.

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA; Greenberg Bladder Cancer Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.01.017DOI Listing
February 2019

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model.

Prostate Cancer Prostatic Dis 2018 04 4;21(1):113-125. Epub 2017 Dec 4.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-017-0013-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897134PMC
April 2018

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.

Cancer Immunol Res 2015 Apr 19;3(4):345-55. Epub 2014 Dec 19.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390444PMC
April 2015

Sustained CD4 T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide.

Oncoimmunology 2014 Jan 3;3(1):e27357. Epub 2014 Jan 3.

Department of Medical Oncology; Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center; Baltimore, MD USA ; James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center; Baltimore, MD USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.27357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004618PMC
January 2014